Log In Sign Up

MSBase investigators to present three oral and six poster presentations at ECTRIMS 2018

Oral Presentations

Sara Eichau, Hospital Universitario Virgen Macarena, Spain 

Familial multiple sclerosis: Comparing demographic and clinical characteristics with sporadic form.

 

Tim Spelman, MSBase statistician

Comparative effectiveness of switching to natalizumab or fingolimod after relapse on first-line relapsing-remitting multiple sclerosis therapy: propensity score matching analysis from the MSBase registry

 

Nathaniel Lizak, supervised by Tomas Kalincik, The Royal Melbourne Hospital, Australia

Determinants of disability accumulation in secondary-progressive multiple sclerosis

 

Poster presentations

Stanley Hum, Montreal Neurological Hospital, Canada

Variability in scoring the Functional System Scores of the Expanded Disability Status Scale at Clinics from Different Countries

 

Amy Kunchok, supervised by Tomas Kalincik, The Royal Melbourne Hospital, Australia

Clinical and therapeutic predictors of relapse and disability outcomes in Neuromyelitis Optica Spectrum Disorder

 

Minh Le, supervised by Tomas Kalincik, The Royal Melbourne Hospital, Australia

Disability outcomes in patients with early cerebellar symptoms in multiple sclerosis

 

Charles Malpas, supervised by Tomas Kalincik, The Royal Melbourne Hospital, Australia

Early Clinical Predictors of Severe MS

 

Anna He, supervised by Tomas Kalincik, The Royal Melbourne Hospital, Australia

To compare patients’ long-term disability outcomes following high efficacy therapy commenced either early or late in their disease course.

 

Hanafi Husin, supervised by Tomas Kalincik, The Royal Melbourne Hospital, Australia

Determinants of MS re-activation after discontinuing therapies

Back